Correcting for Measurement Error in Time-Varying Covariates in Marginal Structural Models.
暂无分享,去创建一个
E. Moodie | M. Abrahamowicz | M. Klein | Erica E. M. Moodie | Marina B. Klein | Ryan P. Kyle | Michał Abrahamowicz | R. P. Kyle | Ryan P Kyle
[1] Yi Shang. Measurement Error Adjustment Using the SIMEX Method: An Application to Student Growth Percentiles , 2012 .
[2] Xihong Lin,et al. Functional Inference in Frailty Measurement Error Models for Clustered Survival Data Using the SIMEX Approach , 2003 .
[3] S. Greenland,et al. The importance of critically interpreting simulation studies. , 1997, Epidemiology.
[4] H Brenner,et al. Controlling for Continuous Confounders in Epidemiologic Research , 1997, Epidemiology.
[5] Jackson T. Wright,et al. Time-updated systolic blood pressure and the progression of chronic kidney disease: a cohort study. , 2015, Annals of internal medicine.
[6] Elizabeth L. Ogburn,et al. Bias attenuation results for nondifferentially mismeasured ordinal and coarsened confounders. , 2013, Biometrika.
[7] Sander Greenland,et al. Commentary: Intuitions, Simulations, Theorems The Role and Limits of Methodology , 2012, Epidemiology.
[8] Robert W Platt,et al. The Effect of Error-in-Confounders on the Estimation of the Causal Parameter When Using Marginal Structural Models and Inverse Probability-of-Treatment Weights: A Simulation Study , 2014, The international journal of biostatistics.
[9] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[10] James W. Hardin,et al. The Simulation Extrapolation Method for Fitting Generalized Linear Models with Additive Measurement Error , 2003 .
[11] C. Cooper,et al. Validation of a simple model for predicting liver fibrosis in HIV/hepatitis C virus‐coinfected patients , 2005, HIV medicine.
[12] J. Brian Gray,et al. Introduction to Linear Regression Analysis , 2002, Technometrics.
[13] J. R. Lockwood,et al. Inverse probability weighting with error-prone covariates. , 2013, Biometrika.
[14] T. Heeren,et al. HIV Infection Does Not Affect the Performance of Noninvasive Markers of Fibrosis for the Diagnosis of Hepatitis C Virus-Related Liver Disease , 2005, Journal of acquired immune deficiency syndromes.
[15] Stef van Buuren,et al. MICE: Multivariate Imputation by Chained Equations in R , 2011 .
[16] Alaa Althubaiti,et al. Non-Gaussian Berkson errors in bioassay , 2016, Statistical methods in medical research.
[17] R. Carroll,et al. Methods for Estimation of Radiation Risk in Epidemiological Studies Accounting for Classical and Berkson Errors in Doses , 2011, The international journal of biostatistics.
[18] S. Cole,et al. Using marginal structural measurement-error models to estimate the long-term effect of antiretroviral therapy on incident AIDS or death. , 2010, American journal of epidemiology.
[19] M. Wulfsohn,et al. A joint model for survival and longitudinal data measured with error. , 1997, Biometrics.
[20] Jon Hill,et al. SPRINT: A new parallel framework for R , 2008, BMC Bioinformatics.
[21] Stephen R Cole,et al. Constructing inverse probability weights for marginal structural models. , 2008, American journal of epidemiology.
[22] J. Kalbfleisch,et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C , 2003, Hepatology.
[23] Raymond J. Carroll,et al. Bias Analysis and SIMEX Approach in Generalized Linear Mixed Measurement Error Models , 1998 .
[24] Leon Jay Gleser,et al. Simex approaches to measurement error in roc studies , 2000 .
[25] M. Ghany,et al. Diagnosis, management, and treatment of hepatitis C: An update , 2009, Hepatology.
[26] J. R. Cook,et al. Simulation-Extrapolation Estimation in Parametric Measurement Error Models , 1994 .
[27] David Hinkley,et al. Bootstrap Methods: Another Look at the Jackknife , 2008 .
[28] Wenqing He,et al. Accelerated failure time models with covariates subject to measurement error , 2007 .
[29] J. Everhart,et al. Association of γ‐glutamyl transferase (GGT) activity with treatment and clinical outcomes in chronic hepatitis C (HCV) , 2013, Hepatology.
[30] Jonathan A C Sterne,et al. The impact of residual and unmeasured confounding in epidemiologic studies: a simulation study. , 2007, American journal of epidemiology.
[31] J. Phair,et al. Effect of CD4+ Cell Count Measurement Variability on Staging HIV‐1 Infection , 1992, Journal of acquired immune deficiency syndromes.
[32] S. Cole,et al. African American race and HIV virological suppression: beyond disparities in clinic attendance. , 2014, American journal of epidemiology.
[33] S. Walmsley,et al. HIV virological rebounds but not blips predict liver fibrosis progression in antiretroviral-treated HIV/hepatitis C virus-coinfected patients , 2014, HIV medicine.
[34] Douglas G Altman,et al. Dichotomizing continuous predictors in multiple regression: a bad idea , 2006, Statistics in medicine.
[35] Romain Neugebauer,et al. An application of model-fitting procedures for marginal structural models. , 2005, American journal of epidemiology.
[36] S Greenland,et al. The effect of misclassification in the presence of covariates. , 1980, American journal of epidemiology.
[37] M. Brookhart,et al. Effect of Pregnancy and the Postpartum Period on Adherence to Antiretroviral Therapy Among HIV-Infected Women Established on Treatment , 2015, Journal of acquired immune deficiency syndromes.
[38] A. Rieger,et al. Revisiting predictors of virologic response to PEGIFN + RBV therapy in HIV‐/HCV‐coinfected patients: the role of metabolic factors and elevated GGT levels , 2014, Journal of viral hepatitis.
[39] Bin Wang,et al. Estimating smooth distribution function in the presence of heteroscedastic measurement errors , 2010, Comput. Stat. Data Anal..
[40] J. Robins,et al. Marginal Structural Models and Causal Inference in Epidemiology , 2000, Epidemiology.
[41] Hong Yang,et al. Cohort profile: the Canadian HIV-hepatitis C co-infection cohort study. , 2010, International journal of epidemiology.
[42] M. Graffar. [Modern epidemiology]. , 1971, Bruxelles medical.
[43] J. Torre-Cisneros,et al. Twelve week post-treatment follow-up predicts sustained virological response to pegylated interferon and ribavirin therapy in HIV/hepatitis C virus co-infected patients. , 2011, The Journal of antimicrobial chemotherapy.
[44] J. Robins,et al. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. , 2000, Epidemiology.
[45] J. Murray,et al. Earlier sustained virologic response end points for regulatory approval and dose selection of hepatitis C therapies. , 2013, Gastroenterology.
[46] M. Wulfsohn,et al. Modeling the Relationship of Survival to Longitudinal Data Measured with Error. Applications to Survival and CD4 Counts in Patients with AIDS , 1995 .
[47] Raymond J. Carroll,et al. Measurement error in nonlinear models: a modern perspective , 2006 .
[48] Erica E. M. Moodie,et al. Using Directed Acyclic Graphs to detect limitations of traditional regression in longitudinal studies , 2010, International Journal of Public Health.
[49] T. Asselah,et al. Twelve weeks posttreatment follow‐up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving pegylated interferon and ribavirin , 2010, Hepatology.
[50] J. Pearl. Causality: Models, Reasoning and Inference , 2000 .
[51] S. Sandberg,et al. A systematic review of data on biological variation for alanine aminotransferase, aspartate aminotransferase and γ-glutamyl transferase , 2013, Clinical chemistry and laboratory medicine.